-
Symbol
-
INBX on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
1,155,416 shares
-
Security Ownership %
-
7.9%
Shares, Excluding Options vs Price
Morgan Stanley ownership in Inhibrx Biosciences, Inc. Common Stock, par value $0.0001 per share (INBX)
11 Feb 2026 - Morgan Stanley has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,155,416 shares of Inhibrx Biosciences, Inc. Common Stock, par value $0.0001 per share (INBX).
This represents 7.9% ownership of the company.
This is the first filing by MORGAN STANLEY disclosing ownership of Inhibrx Biosciences, Inc. Common Stock, par value $0.0001 per share (INBX).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.